USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Molex CVS Dabendorf GMBH

USPTO PatentsView assignee record - 8 granted patents across 8 technology areas, recorded in grant years 2020–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H04B (Transmission).

RSS updates for this company

The verdict

According to USPTO PatentsView, Molex ranks #32,537 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 8 technology areas.

#32,537
of 49,997 US assignees by volume
Top 21%
by Innovation Score (46.5/100)
14.9
avg claims per patent

USPTO PatentsView assignee plate

Corpus R32537 · Foreign Corporation #32,537 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 8 grants
  • MID-PACK #32,537/49,997
  • PHOTO-FINISH Modern Flames
  • CPC-NARROW H04B · 8 areas
  • INNOV-PAR 46.5/100
  • CLAIMS-RICH 14.9 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • SPAN-YRS 2020–2023 · 4y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Modern Flames, LLC. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Molex

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Molex's Innovation Score is 46.5/100 (top 21% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Molex's grants concentrate

Molex CVS Dabendorf GMBH is a focused PatentsView assignee: 8 CPC subclasses with 87.5% of grants classified under H04B (Transmission). Peak complete grant year is 2022 (4 grants) versus a trough of 1 in 2020. By volume, Molex sits between Modern Flames, LLC. and Mori Seiki Co., Ltd..

Molex's three-year grant acceleration

Molex CVS Dabendorf GMBH shows 6 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Molex's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Molex holds 8 patents at rank #32,458, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Molex

By rank, the assignees closest to #32,458 in granted patent volume.

Leaders in H04B (Transmission)

Other assignees with the most granted patents in Molex's primary technology class.

Molex's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

47 Top 21% higher than 79% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 2020202120222023 2
USPTO utility patent grants by year · 2020–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table
Molex CVS Dabendorf GMBH patent grants by year, 2015–2025
Year Patents Granted Share of Period
2020 1 12.5%
2021 1 12.5%
2022 4 50.0%
2023 2 25.0%

Where it ranks

Overall rank by patents

#32,537

of 49,997 tracked assignees

Innovation Score

46.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Molex CVS Dabendorf GMBH's patent record in context - here's where to go next.

  • Molex CVS Dabendorf GMBH's lead technology class is H04B (Transmission), 87.5% of its portfolio - see every assignee active in that class. Explore H04B
  • Ranked #32,537 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Molex CVS Dabendorf GMBH against Modern Flames, LLC., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 46.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.